WallStreetZenWallStreetZen

NASDAQ: ORKA
Oruka Therapeutics Inc Stock Ownership - Who owns Oruka Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Oruka Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Laura Lee SandlerChief Operating Officer2026-03-025,000$7.80
$39.00kBuy
Laura Lee SandlerChief Operating Officer2026-03-022,675$33.81
$90.44kSell
Laura Lee SandlerChief Operating Officer2026-03-022,325$33.28
$77.39kSell
Joana GoncalvesChief Medical Officer2026-02-173,500$6.84
$23.94kBuy
Joana GoncalvesChief Medical Officer2026-02-173,500$7.80
$27.30kBuy
Joana GoncalvesChief Medical Officer2026-02-176,064$32.30
$195.87kSell
Joana GoncalvesChief Medical Officer2026-02-17936$32.78
$30.69kSell
Joana GoncalvesChief Medical Officer2026-01-152,619$32.24
$84.43kSell
Joana GoncalvesChief Medical Officer2026-01-153,500$6.84
$23.94kBuy
Joana GoncalvesChief Medical Officer2026-01-153,500$7.80
$27.30kBuy

1 of 3

ORKA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ORKA insiders and whales buy or sell their stock.

ORKA Shareholders

What type of owners hold Oruka Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
David M. Mott21.11%10,221,465$351.72MInsider
Harry R. Weller21.11%10,221,465$351.72MInsider
Ravi Viswanathan21.11%10,221,465$351.72MInsider
Peter W. Sonsini21.11%10,221,465$351.72MInsider
Scott D. Sandell21.11%10,221,465$351.72MInsider
Jon Sakoda21.11%10,221,465$351.72MInsider
Joshua Makower21.11%10,221,465$351.72MInsider
Krishna Kittu Kolluri21.11%10,221,465$351.72MInsider
Anthony A. Florence Jr.21.11%10,221,465$351.72MInsider
Forest Baskett21.11%10,221,465$351.72MInsider

1 of 3

ORKA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ORKA25.56%74.44%Net BuyingNet Selling
NRIX93.02%6.98%Net SellingNet Selling
NVAX72.27%17.11%Net SellingNet Selling
OLMA78.20%21.80%Net SellingNet Selling
TRVI43.05%56.95%Net Buying
View Top Biotech Stocks

Oruka Therapeutics Stock Ownership FAQ

Who owns Oruka Therapeutics?

Oruka Therapeutics (NASDAQ: ORKA) is owned by 109.17% institutional shareholders, 317.93% Oruka Therapeutics insiders, and 0.00% retail investors. David M. Mott is the largest individual Oruka Therapeutics shareholder, owning 10.22M shares representing 21.11% of the company. David M. Mott's Oruka Therapeutics shares are currently valued at $344.36M.

If you're new to stock investing, here's how to buy Oruka Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.